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1. Introduction 
Platelet membrane contains a few glycoproteins, 
which are important to the aggregation phenomena 
[ 1,2]. Platelets interact with wheat germ agglutinin 
(WGA), possibly through glycoprotein I [3-51, and 
are agglutinated by this lectin. A glycoprotein extract, 
isolated from human platelet plasma membrane, 
exhibits haemagglutination and, in addition, causes 
agglutination of platelets [6]. We have postulated two 
possible mechanisms to explain this activity: 
(1) A lectin is buried in the membrane which, upon 
activation, becomes exposed. 
(2) Both lectin and the receptor may be present at 
the surface of the cell, but are self-neutralized in 
the freely-circulating platelet. 
Once the cell is activated, the pair-complex dissociates 
and intercellular interaction occurs outside the plane 
of the surface membrane. To further examine the avail- 
ability of WGA receptors on the platelet membrane, 
and their possible exposure due to activation, we 
studied the binding of WGA to platelets before and 
during aggregation. 
We demonstrate here that there is no change in the 
binding of 1251-labeled WGA to washed human plate- 
lets, as a result of thrombin or ADP-induced aggrega- 
tion. On the contrary, a marked decrease in the lectin 
binding was observed when the aggregation was per- 
formed in platelet-rich plasma (PRP). 
2. Materials and methods 
Washed platelets were obtained either as a 24 h old 
platelet concentrate from the Central Blood Bank in 
Abbreviations: WGA, wheat germ agglutinin; PRP, platelet- 
rich plasma; PGE,, prostaglandin E,; ADP, adenosine diphos- 
phate 
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Tel Aviv, or fresh, prepared as in [7]. Briefly, blood 
was collected into l/ 10 vol. sodium citrate 3.2% and 
l/20 vol. aspirin 1 mM. After 15 min incubation at 
37”C, the blood was centrifuged at 300 X g for 
10 min to yield the PRP. The PRP was incubated with 
1 /..rM prostaglandin El (PGEi) for 20 min and adjusted 
to pH 6.5 with 0.1 M citric acid. This mixture was 
centrifuged at 1000 X g for 20 min and the platelets 
were resuspended in l-2 ml Tyrode’s solution, con- 
taining 2 mg/ml albumin, 0.02 M Hepes and 0.3 nM 
PGEr. The platelets were separated by gel filtration 
on Sepharose 2B column, equilibrated with the above 
buffer not containing PGEi. 
Platelet-rich plasma (PRP) was obtained by collect- 
ing the blood into l/l0 vol. 3.8% sodium citrate and 
centrifuging 3 times at 300 X g for 10 min each. WGA 
was purchased from Makor .Chem., Jerusalem, and 
iodinated as follows: 1 mg lectin was dissolved in 
200 ~1 borate buffer 0.1 M (pH 8.5) containing 
50 mM N-acetyl-D-glucosamine. This solution was 
added to 50 r.(Ci Bolton and Hunter reagent [8] 
(Radiochemical Centre Amersham) and the mixture 
was incubated at room temperature for 30 min. Glycine 
was added to 1 mM final cont. and after a further 
15 min incubation the mixture was dialyzed against 
cold water for 3 days. Binding of WGA to platelets 
(washed or PRP) was studied in the following way: 
450 ~1 PRP or washed platelets were stirred in the 
Chronolog cuvette and lo-15 ~1 1251-labeled WGA in 
saline (usually 4-8 X lo4 cpm) were added at differ- 
ent stages of the aggregation (initiated by thrombin, 
ADP or epinephrine, as in table 2). After 3 min the 
platelet aggregate was transferred to an Eppendorf 
tube and centrifuged. The platelet pellet was washed 
with saline and counted. Non-specific binding was 
determined by adding the same amount of 12’1-labeled 
WGA to platelets containing 10 mM N-acetyl-D- 
glucosamine. 
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3. Results and discussion 
3.1. Binding of ‘251-labeled WGA to platelets 
Time and concentration curves of rzSI-labeled 
WGA to platelets are shown in fig.l,2. The specific 
binding of WGA to platelets was linear up to 0.1 pg 
lectin/ml, saturation was reached at l-2 fig/ml. From 
table 1, it can be seen that full a~lut~ation of plate- 
lets occurred only at X.5 pg WGA/ml, while at 
<0.05 pg WGA/ml there was no agglutination at all. 
It seems, therefore, that at low lectin concentrations, 
where the binding is linear, there is no agglutination, 
probably because of the low WGA concentration, At 
higher concentrations the platelets tend to be aggluti- 
nated by the lectin with cont~ued binding, but devia- 
tion from linearity. 
The time curve of WGA binding to platelets hows 
that maximal binding is obtained after 41 min (fig.2). 
3.2. Effect of platelet aggregaiion on WGA binding 
The effect of aggregation o  the binding of WGA 
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Fig.1, Concentration curve of wheat germ agglutinin (WGA) 
binding to washed human platelets. 
Time lmcn.) 
Fig.2. Time curve of wheat germ agglutinm (WGA) binding to 
human platelets (in platelet plasma). 
was studied, ‘251-Labeled WGA was added to platelets 
during aggregation i duced by various reagents, at 4 
different points (see legend to table 2), and at the end 
of the aggregation the platelet pellet was isolated and 
the degree of specific binding was determined (see 
section 2). Results are shown in table 2. The binding 
of WGA to washed platelets is not affected by aggre- 
gation initiated by any of the agents used (thromb~, 
ADP, epinephrine), no matter at what stage the lectin 
Table 1 
A~iut~ation of human washed platelets by WGA 







Change in binding of WGA to human platelets 
Washed platelets P~atelet~ich plasma 
Aggregation Aggregation Aggregation Aggregation Aggregation 
by thrombin by ADP by thrombin by ADP by epinephrine 
: 
+10% +8% -275% -210% -60% 
+ 8% -2% -100% -360% -60% 
: 
- 6% n.d. - 2% -120% -17% 
+ 6% n.d. + 10% - 50% 0% 
The change in binding of WGA is expressed in % compared to the binding of the fectin to 
resting platelets: a, WGA added together with aggregation agent; b, WGA added at the 
end of aggregation (usually l-1.5 mm after the addition of aggregating agent); c, WGA 
added 30 s before aggregating agent; d, WGA added 2 mm before aggregating agent; 
n.d., not determined 
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was added. On the contrary, when WGA was added to 
PRP together with or after the aggregating a ent, a 
marked decrease in the lectin binding to the platelets 
was observed. This reduction in the specific binding 
of WGA was up to 700% in a few cases and always 
>tOO%. The fact that this effect was observed only 
in PRP and not in washed platelets indicates that a 
plasma component participates in this phenomenon. 
It seems, that, as a result of platelet activation (in 
PRP), either by thrombin, epinephrine or ADP, a fac- 
tor present in the plasma is activated and competes 
with WGA on binding to the platelets. ~~ycoprotein I 
may be the binding site for WCA on platelet mem- 
brane [2,3,5]. However, glycoprotein I may be also 
involved in the interaction of platelets with plasma 
van W~lebra~d factor [9,101. It is, therefore, possible 
that the binding sites of WGA and von Wi~~ebrand 
factor are identical or at least similar, Another pos- 
sible expianat~on, which cannot be ruled out at this 
stage, is the possible release of a specific component 
from the platelet membrane during activation. This 
component would be part of the WGA binding site 
and present in PRP, but probably lost or jnactivated 
during the preparation of washed platelets. 
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